Open access
809
Views
2
CrossRef citations to date
0
Altmetric
Research Article
Application of HIPEC simulations for optimizing treatment delivery strategies
Daan R. Lökea Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The NetherlandsView further author information
, H. Petra Koka Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The NetherlandsView further author information
, Roxan F. C. P. A Heldermana Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;c Center for Experimental and Molecular Medicine (CEMM), Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam, The NetherlandsView further author information
, Bella Bokana Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;c Center for Experimental and Molecular Medicine (CEMM), Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam, The NetherlandsView further author information
, Nicolaas A. P. Frankena Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;c Center for Experimental and Molecular Medicine (CEMM), Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam, The NetherlandsView further author information
, Arlene L. Oeia Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;c Center for Experimental and Molecular Medicine (CEMM), Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam, The NetherlandsView further author information
, Jurriaan B. Tuynmand Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsView further author information
, Pieter J. Tanise Department of Surgery, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands;f Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The NetherlandsView further author information
& Johannes Crezeea Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The NetherlandsCorrespondence[email protected]
View further author information
show allView further author information
Article: 2218627
|
Received 28 Feb 2023, Accepted 22 May 2023, Published online: 16 Jul 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.